Type 2 Diabetes Trial, Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who are 50 years of age or older
- Women who have gone through menopause, meaning no menstrual period for at least 12 months in a row
- People who do not currently do structured exercise more than 30 minutes, three times per week
- People who weigh at least 110 pounds
- People whose blood sugar levels fall in the prediabetes range (fasting blood glucose of 100–125 mg/dl, or a hemoglobin A1c of 5.7–6.4%)
- People who drink fewer than 8 alcoholic drinks per week (for women) or fewer than 15 per week (for men)
- People who do not use nicotine or cannabis products
- People who are not taking certain medications that could affect the study results — the trial site will review current medications to check whether any fall into the affected categories
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People with a history of nerve damage in the hands or feet (peripheral neuropathy)
- People currently taking prescription blood thinners
- People with physical or health conditions that would make high-intensity cycling exercise unsafe, including joint or bone problems that limit cycling, significant heart problems (such as irregular heartbeat or severely uncontrolled high blood pressure), diagnosed diabetes, kidney disease, sickle cell anemia, or cancer that has been in remission for less than 6 months
- People with a known history of slow wound healing
- People with an allergy to lidocaine (a type of local anaesthetic)
- People with a latex allergy
- People who are currently pregnant
- People with more than 1.5 inches of fat tissue beneath the skin over the thigh muscle
- People experiencing symptoms that may suggest heart, lung, metabolic, or kidney problems — such as chest, jaw, arm, or leg discomfort; shortness of breath at rest or with light activity; dizziness or fainting; breathing difficulties when lying down or at night; a racing or irregular heartbeat; leg cramping during activity; a known heart murmur; ankle swelling; or unusual fatigue during everyday tasks
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Hui-Ying Luk, PhD; Danielle Levitt, PhD, Texas Tech University
Phone: 8068340827
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Glycemic control; Skeletal muscle architecture 1; Skeletal muscle architecture 2; Frailty status; Exercise capacity
Can't join this trial?
Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.